GNH USA

Europe — EMA

Metoprolol Tartrate Milpharm

GNH USA supplies Metoprolol Tartrate Milpharm (Metoprolol Tartrate), a beta blocker for hypertension, angina and cardiac arrhythmias.

Metoprolol Tartrate

Request sourcing

1
Pack/s

What is Metoprolol Tartrate?

Metoprolol Tartrate, the active ingredient in Metoprolol Tartrate Milpharm, is a beta blocker presented as a tablet for oral use. It is used to manage high blood pressure, angina, and certain heart rhythm disorders in adult patients. GNH USA supplies Metoprolol Tartrate Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Metoprolol Tartrate used for?

Metoprolol Tartrate acts on the cardiovascular system to control blood pressure and heart rhythm. - Hypertension: lowers systolic and diastolic pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival after heart attack by limiting workload on the heart. - Heart failure: helps reduce symptoms and hospitalizations by moderating heart rate. - Cardiac arrhythmias: stabilises abnormal heart rhythms by blocking β1‑adrenergic receptors.

What are the side effects of Metoprolol Tartrate?

Metoprolol Tartrate may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort) - Bradycardia (slow heart rate) - Mild depression or mood changes

Serious or Rare Side Effects: - Severe bradycardia or heart block - Acute heart failure exacerbation - Bronchospasm in susceptible individuals - Hypotension with syncope - Allergic reactions (rash, angioedema) - Hyperglycaemia in diabetic patients

What precautions apply to Metoprolol Tartrate?

Before initiating therapy, clinicians should assess patient history and comorbidities. - Cardiovascular disease: evaluate for bradycardia, heart block, or decompensated heart failure. - Respiratory conditions: use cautiously in asthma or COPD due to potential bronchoconstriction. - Diabetes: monitor blood glucose as β‑blockade may mask hypoglycaemia symptoms. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

What does Metoprolol Tartrate interact with?

Metoprolol Tartrate can alter the pharmacokinetics or pharmacodynamics of several co‑administered agents.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): risk of severe bradycardia and AV block. - Antidiabetic sulfonylureas: may enhance hypoglycaemia.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): possible increase in plasma metoprolol levels. - NSAIDs: may reduce antihypertensive effect. - Antithyroid drugs: may blunt tachycardia response.

Frequently asked questions

What conditions is Metoprolol Tartrate Milpharm used for?+
Metoprolol Tartrate Milpharm is prescribed to treat high blood pressure, chronic stable angina, post‑myocardial infarction management, heart failure with reduced ejection fraction, and certain cardiac arrhythmias. It works by slowing the heart rate and reducing the force of contraction, which helps lower arterial pressure and myocardial oxygen demand.
How does Metoprolol Tartrate work in the body?+
The drug selectively blocks β1‑adrenergic receptors located primarily in the heart. By inhibiting the action of adrenaline and noradrenaline on these receptors, it reduces heart rate, myocardial contractility, and conduction velocity, leading to decreased cardiac output and lower blood pressure while preserving β2‑receptor activity in the lungs and vasculature.
What is the usual dose of Metoprolol Tartrate Milpharm?+
The appropriate dose of Metoprolol Tartrate Milpharm is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and tolerability. Dosage adjustments are made according to blood pressure readings, heart rate, and clinical judgment, and should never be altered without professional guidance.
Is Metoprolol Tartrate safe during pregnancy or breastfeeding?+
Safety data for Metoprolol Tartrate in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate each case individually and discuss alternative options when appropriate.
How do I order Metoprolol Tartrate Milpharm from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.
How does Metoprolol Tartrate compare with other beta blockers?+
Metoprolol Tartrate is a cardio‑selective β1‑blocker, offering a favorable profile for patients with hypertension or angina who also have respiratory concerns, as it spares β2 receptors. Compared with non‑selective agents like propranolol, it tends to cause fewer bronchospastic events while providing comparable heart‑rate control.
What are the recommended storage conditions for Metoprolol Tartrate Milpharm?+
Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain product stability throughout its shelf life.
How is Metoprolol Tartrate administered?+
Metoprolol Tartrate Milpharm is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.
What are the most serious risks associated with Metoprolol Tartrate?+
Serious adverse events include severe bradycardia, heart block, hypotension, acute heart‑failure exacerbation, and bronchospasm in patients with underlying respiratory disease. Prompt medical attention is required if symptoms such as fainting, chest pain, or difficulty breathing occur.
Who should not use Metoprolol Tartrate?+
Metoprolol Tartrate is contraindicated in patients with known hypersensitivity to the drug, those with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and individuals in cardiogenic shock. Caution is also advised for patients with uncontrolled asthma or chronic obstructive pulmonary disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Metoprolol Tartrate
Route
Oral Use
Manufacturer
Milpharm Limited
Origin
EU

Related products